Latest UCB News & Updates

See the latest news and media coverage for UCB. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
UCB

Global biopharmaceutical company for neurological and immune‑mediated diseases

ucb.com
Headquarters
Brussels, Belgium
Founded year
1928
Company type
Private company
Number of employees
5,000–15,000

Last updated

Latest news about UCB

In short: UCB expanded its immunology and neurology pipelines through multibillion-dollar acquisitions and a $2 billion investment in a U.S. production site.

Company announcements

UCB

UCB's BIMZELX shows superior efficacy over SKYRIZI in psoriatic arthritis

In a head-to-head trial, bimekizumab achieved significantly higher ACR50 response at Week 16 compared to risankizumab.

Unlock all announcements with a

Media coverage

MSN

UCB completes billion-dollar acquisition

UCB has completed the acquisition of the American biotech company Candid Therapeutics. The Belgian pharmaceutical group announced this on Wednesday. In early May, UCB had already...

Newswire.ca

BIMZELX® (bimekizumab injection) Receives Positive Reimbursement Recommendation from Canada's Drug Agency for Hidradenitis Suppurativa

Following an examination of clinical evidence and stakeholder input, Canada's Drug Agency (CDA-AMC) has recommended BIMZELX® (bimekizumab injection) for reimbursement with conditions for patients with...

Unlock all articles with a

Never miss news about UCB

Track UCB and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

UCB competitors & trending companies

Browse news for competitors to UCB and other trending companies.